FDA Adverse Event Malfunction Summary report: N

BD FACSLYRIC¿

MDR report key: 19537791 · Received June 14, 2024

Report

Report Number
2916837-2024-00036
Event Type
Malfunction
Date Received
June 14, 2024
Date of Event
June 5, 2024
Report Date
August 20, 2024
Manufacturer
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
Product Code
OYE
UDI-DI
00382906635181
PMA / PMN Number
K201814
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

D4: UNIQUE IDENTIFICATION NUMBER: (B)(4). H3. INVESTIGATION SUMMARY: BASED ON THE INVESTIGATION RESULTS, THE REPORTED ISSUE REGARDING CARRYOVER WAS CONFIRMED. INVESTIGATION RESULTS THAT WERE PERFORMED ON THE INDICATED FAILURE MODE WERE THE FOLLOWING: THE POTENTIAL CAUSE FOR THE CARRYOVER WAS PARTIALLY CLOGGED SAMPLE LINE AND POOR SIT FLUSH ASPIRATION. THE CUSTOMER REPORTED AN ISSUE REGARDING THEIR SYSTEM HAVING CARRYOVER ISSUES. THEY NOTED THAT THE CARRYOVER ONLY HAPPENS WHEN RUNNING MANUALLY WITH TUBES. THE FIELD SERVICE REPRESENTATIVE (FSR) PERFORMED A SERVICE VISIT. THEY REPLACED THE SAMPLE LINE AND FLUSHED OUT THE VALVE V8 PINCH VALVE TUBING USING BLEACH SOLUTION. THEY PERFORMED A SERIES OF CALIBRATION AND ALIGNMENT TO VERIFY FUNCTIONALITY. AFTER THE WORKS PERFORMED, THE INSTRUMENT WAS TESTED AND WAS CONFIRMED TO BE FUNCTIONING AS EXPECTED. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. INFORMATION WILL BE CAPTURED ON TREND REPORTS AND MONITORED. OUR BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS.

Additional Manufacturer Narrative · 0

D.4. MEDICAL DEVICE EXPIRATION DATE: NA. E.1.: (B)(6). H.3. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 0

IT WAS REPORTED THAT CARRYOVER WAS OBSERVED IN PATIENT SAMPLES DURING USE WITH THE BD FACSLYRIC¿. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WERE PATIENT SAMPLES CONTAMINATED OR WAS THERE CARRYOVER (CROSS-CONTAMINATION/MIXING) BETWEEN PATIENT SAMPLES? CARRYOVER BETWEEN PATIENT SAMPLES. PLEASE DESCRIBE ANY ADDITIONAL DETAILS: GO TO PATIENT SAMPLES CHECKLIST. SPOKE WITH CUSTOMER AND SHE TOLD ME THEY ARE HAVING ISSUES WITH CARRYOVER BETWEEN SAMPLES WHEN USING THE MANUAL MODE. THAT IS WHY THEY PLACED CALL. SYSTEM WILL NOT BE USED UNTIL SERVICED. SYSTEM IS HAVING CARRYOVER ISSUES.

Description of Event or Problem · 0

IT WAS REPORTED THAT CARRYOVER WAS OBSERVED IN PATIENT SAMPLES DURING USE WITH THE BD FACSLYRIC¿. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WERE PATIENT SAMPLES CONTAMINATED OR WAS THEIR CARRYOVER (CROSS-CONTAMINATION/MIXING) BETWEEN PATIENT SAMPLES? CARRYOVER BETWEEN PATIENT SAMPLES PLEASE DESCRIBE ANY ADDITIONAL DETAILS: GO TO PATIENT SAMPLES CHECKLIST SPOKE WITH CUSTOMER AND SHE TOLD ME THEY ARE HAVING ISSUES WITH CARRYOVER BETWEEN SAMPLES WHEN USING THE MANUAL MODE. THAT IS WHY THEY PLACED CALL. SYSTEM WILL NOT BE USED UNTIL SERVICED. SYSTEM IS HAVING CARRYOVER ISSUES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
184006 BD FACSLYRIC¿ FLOW CYTOMETRIC REAGENTS AND ACCESS OYE BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES 00382906635181

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown